3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors

US7749995B2 · kind B2 · utility

Assignee

• Janssen Pharmaceuticals, Inc. · BE

Inventors

• Gee-Hong Kuo · Scotch Plains, US
• Aihua Wang · Jamison, US
• Thomas A. Rano · Somerville, US
• Catherine P. Prouty · Doylestown, US
• Keith Demarest · Flemington, US
• Patricia Pelton · Long Valley, US

Key dates

• Filing date: May 10, 2007
• Grant date: Jul 6, 2010
• Expiry date: Aug 16, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D279/16
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention is directed to compounds of Formula (I) described herein useful as CETP inhibitors, compositions containing them, and methods of using them.